2,890 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Bought by CWA Asset Management Group LLC

CWA Asset Management Group LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,890 shares of the financial services provider’s stock, valued at approximately $382,000.

Other hedge funds also recently made changes to their positions in the company. Security National Bank of SO Dak lifted its position in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after buying an additional 75 shares during the period. SPC Financial Inc. lifted its holdings in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after acquiring an additional 75 shares during the period. Werba Rubin Papier Wealth Management boosted its stake in shares of iShares Biotechnology ETF by 2.7% in the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares in the last quarter. Main Street Financial Solutions LLC grew its holdings in shares of iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after purchasing an additional 82 shares during the last quarter. Finally, Prairie Wealth Advisors Inc. increased its position in shares of iShares Biotechnology ETF by 6.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock worth $242,000 after purchasing an additional 100 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $134.83 on Thursday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The company’s 50-day moving average price is $138.26 and its two-hundred day moving average price is $142.05.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.